We are involved in the search for new markers and protein targets in cancer

At Onkologikoa we collaborate with Biodonostia on several programmes to develop new cancer biomarkers.

Biomarkers are characteristics of cancer cells (or of other patient cells) that give us a better idea of the particular characteristics of a tumour and match it to the best treatment or even enable the development of new therapies.

Thanks to several collaboration projects with Biodonostia, professionals at Onkologikoa research new biomarkers, particularly for breast cancer. We study markers which characterise, on the one hand, response to conventional therapies, or indicate resistance to them, and, on the other, new markers which may become protein targets for new drugs in the future.

You may also be interested in


The Onkologikoa Foundation is a pioneer in the robotic preparation of chemotherapy thanks to its collaboration with the Kiro-Grifols company in designing and developing the…

Continue reading

The Basque Health Cluster groups health sector companies with a view to promoting economic development. For two years now, Onkologikoa has been collaborating as an…

Continue reading

We'll call you in 24 hours

Fill in your details and tell us why you're calling, so that we can deal with you in the most personal and efficient way possible.

You can call us too if you'd rather.